Live Breaking News & Updates on Better Medical Group

Anatara Lifesciences Limited (ASX:ANR) Chair Transition
  
Chair TransitionMelbourne, July 26, 2021 AEST (ABN Newswire) - Anatara Lifesciences (
ASX:ANR), a developer of evidence-based solutions for gastrointestinal diseases in humans and animals, is pleased to announce the transition of Dr David Brookes from Non-Executive Director to Chairman. Sue MacLeman will continue on the Board, transitioning from Chair to Non-Executive Director.
The Board determined that, having successfully steered the Company following its decision to focus on the development of products and technologies in the human health sector with a focus on gut health, the time was now right for Dr Brookes to transition to the role of Chair as the Company progresses towards clinical trials. ....

Steven Lydeamore , Anatara Lifesciences , David Brookes , Island Pharmaceuticals Ltd , Better Medical Group , Anatara Lifesciences Ltd , Australian College Of Rural , Perkinelmer Inc , Tali Digital Ltd , Non Executive Director , Sue Macleman , Non Executive Chairman , Factor Therapeutics , Australian College , Remote Medicine , Anatara Chair , டேவிட் ப்ரூக்ஸ் , ஆஸ்திரேலிய கல்லூரி ஆஃப் கிராமப்புற , தாலி டிஜிட்டல் லிமிடெட் , அல்லாத நிர்வாகி இயக்குனர் , அல்லாத நிர்வாகி தலைவர் , காரணி சிகிச்சை , ஆஸ்திரேலிய கல்லூரி , தொலைநிலை மருந்து ,